Mirae Asset Global ETFs Holdings’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.19M Buy
76,682
+14,009
+22% +$305K ﹤0.01% 1194
2026
Q1
$1.08M Buy
62,673
+1,157
+2% +$21.9K ﹤0.01% 1484
2025
Q4
$1.16M Sell
61,516
-3,136
-5% -$52.5K ﹤0.01% 1434
2025
Q3
$942K Sell
64,652
-4,082
-6% -$58.2K ﹤0.01% 1522
2025
Q2
$1.34M Sell
68,734
-39,882
-37% -$709K ﹤0.01% 1291
2025
Q1
$1.93M Sell
108,616
-3,824
-3% -$82.4K ﹤0.01% 1162
2024
Q4
$2.41M Buy
112,440
+4,897
+5% +$119K 0.01% 1033
2024
Q3
$3.35M Sell
107,543
-15,539
-13% -$387K 0.01% 894
2024
Q2
$1.91M Buy
+123,082
New +$1.49M ﹤0.01% 1099

Other funds holding CDNA

Mirae Asset Global ETFs Holdings's CDNA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its CareDx (CDNA) stake by 22% in Q2 2026, buying an estimated $305K and bringing the position to 76,682 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1194.

Mirae Asset Global ETFs Holdings first reported a position in CDNA in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.35M in Q3 2024. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 76,682 shares of CareDx worth $2.19M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 14,009 CareDx shares in Q2 2026, an estimated $305K.
  • CareDx made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1194 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in CareDx in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's CareDx position peaked at $3.35M in Q3 2024.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.